Press Releases Our latest news and press releases All 2021 2020 2019 2018 2017 2016 18 NOV 2021 13:44 E.S.T. Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK Partnership to Enable Broader Collaboration in China READ MORE 11 NOV 2021 17:19 E.S.T. Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Product Candidate Targeting Mesothelin to Treat Solid Tumors at the Annual Meeting of the Society for Immunotherapy of Cancer READ MORE 04 NOV 2021 14:51 E.S.T. Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021 READ MORE 03 NOV 2021 18:40 E.S.T. Cellectis Announces Release of Abstracts at ASH Showcasing Updated Preliminary Clinical Data from BALLI-01 Study and First Preclinical Data from TALGlobin01 READ MORE 28 OCT 2021 11:08 E.S.T. Cellectis to Hold Third Quarter Earnings Call on Friday, November 5, 2021 at 8AM EDT READ MORE 19 OCT 2021 14:19 E.S.T. Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021 READ MORE 12 OCT 2021 14:53 E.S.T. Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting READ MORE 26 AUG 2021 14:38 E.S.T. Cellectis Announces Participation in Five Investor Conferences READ MORE 05 AUG 2021 14:43 E.S.T. Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021 READ MORE 29 JUL 2021 16:06 E.S.T. Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT READ MORE 123 NEXT Press contacts For more information on any story, or for press enquiries, get in touch with our Media Team. CONTACT US LEGAL NOTICEGLOSSARYMEDIA LIBRARYCONTACTCOMMUNITY GUIDELINES Subsidiary: Calyxt Inc.